Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond

Jonathan Corren,Christopher E. Brightling,Louis-Philippe Boulet,Celeste Porsbjerg,Michael E. Wechsler,Andrew Menzies-Gow,Christopher S. Ambrose,Bill Cook,Neil Martin,Joseph Spahn,Jean-Pierre Llanos

The European respiratory journal（2023）

引用 1|浏览48

暂无评分

摘要

Tezepelumab, a biologic therapy for severe asthma, blocks TSLP activity, subsequently downregulating multiple type 2 inflammatory pathways and reducing airway hyperresponsiveness via eosinophil-independent effects https://bit.ly/3XGpaV3

查看译文

关键词

tezepelumab treatment,asthma,anti-eosinophil

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要